News & Updates
Filter by Specialty:
HoLEP, RASP deliver equally excellent postoperative outcomes in benign prostatic hyperplasia
The use of holmium laser enucleation of the prostate (HoLEP) and robotic-assisted simple prostatectomy (RASP) deliver comparable and good postoperative outcomes in patients with large benign prostatic hyperplasia (BPH), a new study has found.
HoLEP, RASP deliver equally excellent postoperative outcomes in benign prostatic hyperplasia
12 Jun 2022
Frail women at risk of complications, repeat procedure after sling surgery
Frailty is associated with a higher relative risk of 30-day complications, 1-year mortality, and repeat procedures for persistent incontinence or obstructed voiding at 1 year after sling surgery in older adults, suggests a recent study.
Frail women at risk of complications, repeat procedure after sling surgery
07 Jun 2022
Polycythemia ups risk of MACE, VTE in men on testosterone therapy
Men receiving testosterone therapy (TT) who develop polycythemia are at greater risk for major adverse cardiovascular events (MACE) and venous thromboembolism (VTE) in the first year of therapy, according to a recent study.
Polycythemia ups risk of MACE, VTE in men on testosterone therapy
06 Jun 2022
Whole pelvic radiation therapy improves survival in high-risk prostate cancer
Prostate cancer (PCa) patients with higher lymph node (LN) risk scores and Gleason grade who are treated with whole pelvis radiotherapy (WPRT) have better overall survival (OS), reports a study.
Whole pelvic radiation therapy improves survival in high-risk prostate cancer
02 Jun 2022
Chemoradiotherapy improves disease control in muscle-invasive bladder cancer
Chemotherapy with 5-fluorouracil (5FU) and mitomycin C (MMC), when combined with radiotherapy, leads to better locoregional control over a 10-year window in patients with muscle-invasive bladder cancer (MIBC), a recent study has found.
